🇪🇺EU · EMAExpiredATC: J07BB02

Focetria(Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181)

Influenza, Human;Immunization;Disease Outbreaks

Marketing Authorisation Holder: Novartis Vaccines and Diagnostics S.r.l.

EMA Authorisation: 02/05/2007

INN: influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted)

Indication

Prophylaxis of influenza caused by A (H1N1v) 2009 virus. Focetria should be used in accordance with official guidance.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Focetria — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Focetria Create Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.